Max Robotics — Global Service Robot Directory + US Certification

About

David Schilling is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes and patient quality of life in prostate cancer care. His research focuses on two key areas: identifying modifiable risk factors for postoperative complications and understanding patient-centered outcomes following radical prostatectomy. In his highly cited 2013 study (21 citations), Schilling demonstrated that surgical approach and body mass index significantly influence the development of symptomatic lymphoceles after radical prostatectomy, providing critical guidance for perioperative management. More recently, his landmark multicenter IMPROVE study (2022, 9 citations) revealed a striking finding: patients who underwent robot-assisted radical prostatectomy reported significantly less regret about their treatment choice compared to those who had open surgery. This patient-reported outcome measure has profound implications for shared decision-making and surgical counseling. Schilling’s work bridges technical surgical innovation with the lived experience of patients, establishing him as a key voice in evidence-based, patient-centered urologic oncology. His contributions continue to shape surgical practice and improve recovery for men with prostate cancer.